Credit Agricole
AMLX icon

Credit Agricole’s Amylyx Pharmaceuticals AMLX Stock Holding History

Credit Agricole’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$9.15K – 920
2023
Q3 		$9.15K Buy
500
+300
+150% +$6.34K ﹤0.01% 851
2023
Q2 		$4.31K Hold
200
– – ﹤0.01% 647
2023
Q1 		$5.87K Hold
200
– – ﹤0.01% 605
2022
Q4 		$7.39K Sell
200
-300
-60% -$10.6K ﹤0.01% 633
2022
Q3 		$14K Hold
500
– – ﹤0.01% 585
2022
Q2 		$10K Buy
+500
New +$5.94K ﹤0.01% 606

Other funds holding AMLX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole's AMLX Position: Q4 2023 in Review

Credit Agricole sold out of Amylyx Pharmaceuticals (AMLX) in Q4 2023, closing a stake of 500 shares — an estimated $9.15K sold.

Credit Agricole first reported a position in AMLX in Q2 2022 and held it in 6 quarters. The position peaked at $14K in Q3 2022. 178 funds tracked by Wall St. Rank hold AMLX as of Q4 2023.

  • Credit Agricole reported no remaining Amylyx Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Credit Agricole sold 500 Amylyx Pharmaceuticals shares in Q4 2023, an estimated $9.15K.
  • Credit Agricole first reported a position in Amylyx Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • Credit Agricole's Amylyx Pharmaceuticals position peaked at $14K in Q3 2022.
  • 178 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q4 2023.

Based on Credit Agricole's 13F filing for Q4 2023, filed 13 Feb 2024.